nodes	percent_of_prediction	percent_of_DWPC	metapath
Leflunomide—DHODH—pituitary gland—polycystic ovary syndrome	0.0213	0.0611	CbGeAlD
Leflunomide—DHODH—adipose tissue—polycystic ovary syndrome	0.0212	0.0608	CbGeAlD
Leflunomide—PTK2B—embryo—polycystic ovary syndrome	0.0204	0.0584	CbGeAlD
Leflunomide—CYP1A2—urine—polycystic ovary syndrome	0.0194	0.0554	CbGeAlD
Leflunomide—DHODH—adrenal gland—polycystic ovary syndrome	0.019	0.0545	CbGeAlD
Leflunomide—CYP2C9—urine—polycystic ovary syndrome	0.0184	0.0526	CbGeAlD
Leflunomide—DHODH—female gonad—polycystic ovary syndrome	0.0178	0.0509	CbGeAlD
Leflunomide—DHODH—endocrine gland—polycystic ovary syndrome	0.0165	0.0473	CbGeAlD
Leflunomide—Appetite absent—Metformin—polycystic ovary syndrome	0.0141	0.0627	CcSEcCtD
Leflunomide—AHR—adrenal cortex—polycystic ovary syndrome	0.0137	0.0393	CbGeAlD
Leflunomide—PTK2B—adipose tissue—polycystic ovary syndrome	0.0134	0.0385	CbGeAlD
Leflunomide—AHR—endometrium—polycystic ovary syndrome	0.0123	0.0351	CbGeAlD
Leflunomide—PTK2B—adrenal gland—polycystic ovary syndrome	0.0121	0.0346	CbGeAlD
Leflunomide—AHR—uterus—polycystic ovary syndrome	0.0113	0.0324	CbGeAlD
Leflunomide—PTK2B—female gonad—polycystic ovary syndrome	0.0112	0.0322	CbGeAlD
Leflunomide—PTK2B—vagina—polycystic ovary syndrome	0.0112	0.032	CbGeAlD
Leflunomide—AHR—pituitary gland—polycystic ovary syndrome	0.0111	0.0318	CbGeAlD
Leflunomide—AHR—adipose tissue—polycystic ovary syndrome	0.0111	0.0317	CbGeAlD
Leflunomide—Nail disorder—Metformin—polycystic ovary syndrome	0.0108	0.0481	CcSEcCtD
Leflunomide—PTK2B—endocrine gland—polycystic ovary syndrome	0.0105	0.03	CbGeAlD
Leflunomide—AHR—adrenal gland—polycystic ovary syndrome	0.00992	0.0284	CbGeAlD
Leflunomide—AHR—female gonad—polycystic ovary syndrome	0.00925	0.0265	CbGeAlD
Leflunomide—AHR—vagina—polycystic ovary syndrome	0.00919	0.0263	CbGeAlD
Leflunomide—AHR—endocrine gland—polycystic ovary syndrome	0.0086	0.0246	CbGeAlD
Leflunomide—Blood disorder—Metformin—polycystic ovary syndrome	0.00842	0.0373	CcSEcCtD
Leflunomide—Contusion—Metformin—polycystic ovary syndrome	0.00806	0.0358	CcSEcCtD
Leflunomide—ABCG2—adrenal cortex—polycystic ovary syndrome	0.00533	0.0153	CbGeAlD
Leflunomide—Migraine—Metformin—polycystic ovary syndrome	0.00502	0.0223	CcSEcCtD
Leflunomide—ABCG2—endometrium—polycystic ovary syndrome	0.00476	0.0136	CbGeAlD
Leflunomide—Liver function test abnormal—Metformin—polycystic ovary syndrome	0.00471	0.0209	CcSEcCtD
Leflunomide—Breast disorder—Metformin—polycystic ovary syndrome	0.00461	0.0205	CcSEcCtD
Leflunomide—Cramp muscle—Metformin—polycystic ovary syndrome	0.0046	0.0204	CcSEcCtD
Leflunomide—Influenza—Metformin—polycystic ovary syndrome	0.00441	0.0196	CcSEcCtD
Leflunomide—ABCG2—uterus—polycystic ovary syndrome	0.00438	0.0126	CbGeAlD
Leflunomide—Pancreatitis—Metformin—polycystic ovary syndrome	0.00433	0.0192	CcSEcCtD
Leflunomide—ABCG2—pituitary gland—polycystic ovary syndrome	0.00431	0.0123	CbGeAlD
Leflunomide—Sweating increased—Metformin—polycystic ovary syndrome	0.0043	0.0191	CcSEcCtD
Leflunomide—Angina pectoris—Metformin—polycystic ovary syndrome	0.0043	0.0191	CcSEcCtD
Leflunomide—ABCG2—adipose tissue—polycystic ovary syndrome	0.00429	0.0123	CbGeAlD
Leflunomide—Neutropenia—Metformin—polycystic ovary syndrome	0.00413	0.0183	CcSEcCtD
Leflunomide—Upper respiratory tract infection—Metformin—polycystic ovary syndrome	0.0041	0.0182	CcSEcCtD
Leflunomide—Infestation NOS—Metformin—polycystic ovary syndrome	0.00393	0.0175	CcSEcCtD
Leflunomide—Infestation—Metformin—polycystic ovary syndrome	0.00393	0.0175	CcSEcCtD
Leflunomide—Neuropathy peripheral—Metformin—polycystic ovary syndrome	0.00386	0.0171	CcSEcCtD
Leflunomide—ABCG2—adrenal gland—polycystic ovary syndrome	0.00385	0.011	CbGeAlD
Leflunomide—Hepatobiliary disease—Metformin—polycystic ovary syndrome	0.00372	0.0165	CcSEcCtD
Leflunomide—ABCG2—female gonad—polycystic ovary syndrome	0.00359	0.0103	CbGeAlD
Leflunomide—ABCG2—vagina—polycystic ovary syndrome	0.00356	0.0102	CbGeAlD
Leflunomide—Rhinitis—Metformin—polycystic ovary syndrome	0.00354	0.0157	CcSEcCtD
Leflunomide—Hepatitis—Metformin—polycystic ovary syndrome	0.00353	0.0157	CcSEcCtD
Leflunomide—Oedema peripheral—Metformin—polycystic ovary syndrome	0.00348	0.0154	CcSEcCtD
Leflunomide—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.00347	0.0154	CcSEcCtD
Leflunomide—Eye disorder—Metformin—polycystic ovary syndrome	0.0033	0.0146	CcSEcCtD
Leflunomide—Cardiac disorder—Metformin—polycystic ovary syndrome	0.00328	0.0145	CcSEcCtD
Leflunomide—CYP1A2—endocrine gland—polycystic ovary syndrome	0.00321	0.00919	CbGeAlD
Leflunomide—Immune system disorder—Metformin—polycystic ovary syndrome	0.00319	0.0141	CcSEcCtD
Leflunomide—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.00318	0.0141	CcSEcCtD
Leflunomide—Chills—Metformin—polycystic ovary syndrome	0.00317	0.0141	CcSEcCtD
Leflunomide—Malnutrition—Metformin—polycystic ovary syndrome	0.00307	0.0136	CcSEcCtD
Leflunomide—CYP2C9—endocrine gland—polycystic ovary syndrome	0.00305	0.00873	CbGeAlD
Leflunomide—Flatulence—Metformin—polycystic ovary syndrome	0.00303	0.0134	CcSEcCtD
Leflunomide—Dysgeusia—Metformin—polycystic ovary syndrome	0.00301	0.0134	CcSEcCtD
Leflunomide—Muscle spasms—Metformin—polycystic ovary syndrome	0.00296	0.0131	CcSEcCtD
Leflunomide—Vision blurred—Metformin—polycystic ovary syndrome	0.0029	0.0129	CcSEcCtD
Leflunomide—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.00285	0.0127	CcSEcCtD
Leflunomide—Malaise—Metformin—polycystic ovary syndrome	0.00277	0.0123	CcSEcCtD
Leflunomide—Palpitations—Metformin—polycystic ovary syndrome	0.00272	0.0121	CcSEcCtD
Leflunomide—Hypertension—Metformin—polycystic ovary syndrome	0.00265	0.0118	CcSEcCtD
Leflunomide—Chest pain—Metformin—polycystic ovary syndrome	0.00262	0.0116	CcSEcCtD
Leflunomide—Myalgia—Metformin—polycystic ovary syndrome	0.00262	0.0116	CcSEcCtD
Leflunomide—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.0026	0.0115	CcSEcCtD
Leflunomide—Discomfort—Metformin—polycystic ovary syndrome	0.00259	0.0115	CcSEcCtD
Leflunomide—Infection—Metformin—polycystic ovary syndrome	0.00249	0.0111	CcSEcCtD
Leflunomide—Nervous system disorder—Metformin—polycystic ovary syndrome	0.00246	0.0109	CcSEcCtD
Leflunomide—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.00246	0.0109	CcSEcCtD
Leflunomide—Skin disorder—Metformin—polycystic ovary syndrome	0.00244	0.0108	CcSEcCtD
Leflunomide—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.00243	0.0108	CcSEcCtD
Leflunomide—Anorexia—Metformin—polycystic ovary syndrome	0.00239	0.0106	CcSEcCtD
Leflunomide—Hypotension—Metformin—polycystic ovary syndrome	0.00234	0.0104	CcSEcCtD
Leflunomide—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.00229	0.0101	CcSEcCtD
Leflunomide—Paraesthesia—Metformin—polycystic ovary syndrome	0.00225	0.00999	CcSEcCtD
Leflunomide—Dyspnoea—Metformin—polycystic ovary syndrome	0.00224	0.00992	CcSEcCtD
Leflunomide—Dyspepsia—Metformin—polycystic ovary syndrome	0.00221	0.0098	CcSEcCtD
Leflunomide—Decreased appetite—Metformin—polycystic ovary syndrome	0.00218	0.00967	CcSEcCtD
Leflunomide—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.00217	0.00961	CcSEcCtD
Leflunomide—Fatigue—Metformin—polycystic ovary syndrome	0.00216	0.0096	CcSEcCtD
Leflunomide—Constipation—Metformin—polycystic ovary syndrome	0.00215	0.00952	CcSEcCtD
Leflunomide—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00207	0.00917	CcSEcCtD
Leflunomide—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.00205	0.0091	CcSEcCtD
Leflunomide—Urticaria—Metformin—polycystic ovary syndrome	0.00199	0.00884	CcSEcCtD
Leflunomide—Abdominal pain—Metformin—polycystic ovary syndrome	0.00198	0.0088	CcSEcCtD
Leflunomide—Asthenia—Metformin—polycystic ovary syndrome	0.0018	0.00799	CcSEcCtD
Leflunomide—Pruritus—Metformin—polycystic ovary syndrome	0.00178	0.00787	CcSEcCtD
Leflunomide—Diarrhoea—Metformin—polycystic ovary syndrome	0.00172	0.00761	CcSEcCtD
Leflunomide—Dizziness—Metformin—polycystic ovary syndrome	0.00166	0.00736	CcSEcCtD
Leflunomide—Vomiting—Metformin—polycystic ovary syndrome	0.0016	0.00708	CcSEcCtD
Leflunomide—Rash—Metformin—polycystic ovary syndrome	0.00158	0.00702	CcSEcCtD
Leflunomide—Dermatitis—Metformin—polycystic ovary syndrome	0.00158	0.00701	CcSEcCtD
Leflunomide—Headache—Metformin—polycystic ovary syndrome	0.00157	0.00697	CcSEcCtD
Leflunomide—Nausea—Metformin—polycystic ovary syndrome	0.00149	0.00661	CcSEcCtD
Leflunomide—CYP1A2—Arachidonic acid metabolism—CYP1A1—polycystic ovary syndrome	0.000501	0.00118	CbGpPWpGaD
Leflunomide—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.0005	0.00118	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.000495	0.00116	CbGpPWpGaD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—IRS1—polycystic ovary syndrome	0.000488	0.00115	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—RACGAP1—polycystic ovary syndrome	0.000486	0.00114	CbGpPWpGaD
Leflunomide—AHR—Circadian rythm related genes—IL6—polycystic ovary syndrome	0.000485	0.00114	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—NCOR1—polycystic ovary syndrome	0.000482	0.00113	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—CYP1A1—polycystic ovary syndrome	0.000457	0.00107	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.000456	0.00107	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.000456	0.00107	CbGpPWpGaD
Leflunomide—CYP2C9—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000445	0.00105	CbGpPWpGaD
Leflunomide—PTK2B—VEGFA-VEGFR2 Pathway—IL6—polycystic ovary syndrome	0.00044	0.00104	CbGpPWpGaD
Leflunomide—PTK2B—Signaling by Interleukins—IL6—polycystic ovary syndrome	0.000437	0.00103	CbGpPWpGaD
Leflunomide—CYP1A2—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.000436	0.00102	CbGpPWpGaD
Leflunomide—ABCG2—HIF-1-alpha transcription factor network—VEGFA—polycystic ovary syndrome	0.000436	0.00102	CbGpPWpGaD
Leflunomide—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.000433	0.00102	CbGpPWpGaD
Leflunomide—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.000428	0.00101	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000427	0.001	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—MTHFR—polycystic ovary syndrome	0.000426	0.001	CbGpPWpGaD
Leflunomide—PTK2B—Signaling by VEGF—IL6—polycystic ovary syndrome	0.000416	0.000977	CbGpPWpGaD
Leflunomide—CYP2C9—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000416	0.000977	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.000414	0.000974	CbGpPWpGaD
Leflunomide—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000411	0.000966	CbGpPWpGaD
Leflunomide—CYP2C9—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.00041	0.000964	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.000403	0.000948	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—FGF18—polycystic ovary syndrome	0.000395	0.000928	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.000394	0.000927	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000393	0.000923	CbGpPWpGaD
Leflunomide—CYP1A2—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000381	0.000895	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—NMNAT3—polycystic ovary syndrome	0.00038	0.000894	CbGpPWpGaD
Leflunomide—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000378	0.000889	CbGpPWpGaD
Leflunomide—CYP2C9—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000368	0.000866	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000367	0.000862	CbGpPWpGaD
Leflunomide—CYP2C9—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000363	0.000854	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—GAB1—polycystic ovary syndrome	0.000361	0.000848	CbGpPWpGaD
Leflunomide—CYP1A2—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000355	0.000835	CbGpPWpGaD
Leflunomide—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000351	0.000826	CbGpPWpGaD
Leflunomide—CYP1A2—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.00035	0.000824	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—SUOX—polycystic ovary syndrome	0.000348	0.000818	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—LPCAT2—polycystic ovary syndrome	0.000348	0.000818	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—PPARG—polycystic ovary syndrome	0.000346	0.000812	CbGpPWpGaD
Leflunomide—CYP2C9—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000343	0.000806	CbGpPWpGaD
Leflunomide—CYP2C9—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000342	0.000805	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—POMC—polycystic ovary syndrome	0.000341	0.000801	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—INS—polycystic ovary syndrome	0.000339	0.000797	CbGpPWpGaD
Leflunomide—CYP2C9—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000338	0.000794	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.000337	0.000792	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000334	0.000785	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—CAMK2D—polycystic ovary syndrome	0.000328	0.00077	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—ISYNA1—polycystic ovary syndrome	0.000323	0.00076	CbGpPWpGaD
Leflunomide—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000323	0.000759	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—TNRC6B—polycystic ovary syndrome	0.000322	0.000758	CbGpPWpGaD
Leflunomide—CYP1A2—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000315	0.00074	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000314	0.000738	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.000312	0.000733	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.000312	0.000733	CbGpPWpGaD
Leflunomide—CYP1A2—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.00031	0.00073	CbGpPWpGaD
Leflunomide—CYP2C9—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000307	0.00072	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000306	0.000718	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—FST—polycystic ovary syndrome	0.000298	0.0007	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000294	0.000691	CbGpPWpGaD
Leflunomide—CYP1A2—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000293	0.000689	CbGpPWpGaD
Leflunomide—CYP1A2—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000293	0.000688	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—LHB—polycystic ovary syndrome	0.000291	0.000683	CbGpPWpGaD
Leflunomide—CYP1A2—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000289	0.000678	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000284	0.000668	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—ATF1—polycystic ovary syndrome	0.000283	0.000665	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000275	0.000647	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—TEAD2—polycystic ovary syndrome	0.000275	0.000646	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—AKR1C2—polycystic ovary syndrome	0.000275	0.000646	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—SCT—polycystic ovary syndrome	0.000272	0.00064	CbGpPWpGaD
Leflunomide—CYP2C9—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000271	0.000637	CbGpPWpGaD
Leflunomide—CYP2C9—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000267	0.000628	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.000266	0.000626	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.000266	0.000626	CbGpPWpGaD
Leflunomide—CYP1A2—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000262	0.000616	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.000261	0.000614	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—TAB1—polycystic ovary syndrome	0.000261	0.000614	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.00026	0.000611	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—PRL—polycystic ovary syndrome	0.000259	0.000609	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000255	0.0006	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000253	0.000595	CbGpPWpGaD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—polycystic ovary syndrome	0.000251	0.00059	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.000248	0.000582	CbGpPWpGaD
Leflunomide—ABCG2—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000245	0.000576	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000236	0.000556	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.000236	0.000556	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000233	0.000548	CbGpPWpGaD
Leflunomide—CYP1A2—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000232	0.000544	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—PNPLA2—polycystic ovary syndrome	0.00023	0.000542	CbGpPWpGaD
Leflunomide—CYP1A2—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000228	0.000537	CbGpPWpGaD
Leflunomide—ABCG2—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000228	0.000535	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.000223	0.000525	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—INSR—polycystic ovary syndrome	0.000223	0.000524	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—SRD5A1—polycystic ovary syndrome	0.000218	0.000513	CbGpPWpGaD
Leflunomide—CYP2C9—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000218	0.000513	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—IL18—polycystic ovary syndrome	0.000218	0.000512	CbGpPWpGaD
Leflunomide—CYP2C9—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000215	0.000506	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—NRG1—polycystic ovary syndrome	0.000213	0.000501	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000212	0.000498	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.000212	0.000498	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000208	0.00049	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—STAR—polycystic ovary syndrome	0.000208	0.00049	CbGpPWpGaD
Leflunomide—ABCG2—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000208	0.00049	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—PGR—polycystic ovary syndrome	0.000206	0.000485	CbGpPWpGaD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—IL6—polycystic ovary syndrome	0.000204	0.00048	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.000202	0.000475	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000201	0.000472	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—NMNAT3—polycystic ovary syndrome	0.000192	0.000452	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000192	0.000451	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000192	0.000451	CbGpPWpGaD
Leflunomide—CYP1A2—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000187	0.000439	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—HMMR—polycystic ovary syndrome	0.000186	0.000437	CbGpPWpGaD
Leflunomide—CYP1A2—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000184	0.000433	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000183	0.000431	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000183	0.00043	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—CRP—polycystic ovary syndrome	0.000182	0.000429	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—IRS2—polycystic ovary syndrome	0.000182	0.000429	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000179	0.000421	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000178	0.00042	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—HSD3B1—polycystic ovary syndrome	0.000177	0.000416	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—SUOX—polycystic ovary syndrome	0.000176	0.000413	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—LPCAT2—polycystic ovary syndrome	0.000176	0.000413	CbGpPWpGaD
Leflunomide—ABCG2—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000175	0.000411	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000173	0.000408	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000172	0.000404	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000169	0.000397	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—PRL—polycystic ovary syndrome	0.000167	0.000393	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—NMNAT3—polycystic ovary syndrome	0.000164	0.000386	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—ISYNA1—polycystic ovary syndrome	0.000163	0.000384	CbGpPWpGaD
Leflunomide—CYP2C9—Biological oxidations—POMC—polycystic ovary syndrome	0.000163	0.000383	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—LHB—polycystic ovary syndrome	0.000162	0.00038	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.00016	0.000375	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—IRS1—polycystic ovary syndrome	0.000159	0.000374	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000159	0.000373	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—HSD3B2—polycystic ovary syndrome	0.000158	0.000371	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000157	0.000368	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000153	0.00036	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—AKR1C1—polycystic ovary syndrome	0.000153	0.00036	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—LPCAT2—polycystic ovary syndrome	0.00015	0.000353	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—SUOX—polycystic ovary syndrome	0.00015	0.000353	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000149	0.00035	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000148	0.000348	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—AKT2—polycystic ovary syndrome	0.000147	0.000347	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000147	0.000346	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000141	0.000332	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—SULT2A1—polycystic ovary syndrome	0.000141	0.000331	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.00014	0.00033	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—ISYNA1—polycystic ovary syndrome	0.00014	0.000328	CbGpPWpGaD
Leflunomide—CYP1A2—Biological oxidations—POMC—polycystic ovary syndrome	0.000139	0.000327	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—TEAD2—polycystic ovary syndrome	0.000139	0.000326	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—AKR1C2—polycystic ovary syndrome	0.000139	0.000326	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000138	0.000324	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000136	0.000321	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—RRM2—polycystic ovary syndrome	0.000136	0.00032	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000134	0.000314	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000131	0.000309	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—YAP1—polycystic ovary syndrome	0.000131	0.000309	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—BCL2—polycystic ovary syndrome	0.000129	0.000303	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000127	0.000299	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—NAMPT—polycystic ovary syndrome	0.000126	0.000297	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—CYP11A1—polycystic ovary syndrome	0.000125	0.000293	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000121	0.000284	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—AKR1C2—polycystic ovary syndrome	0.000119	0.000279	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—TEAD2—polycystic ovary syndrome	0.000119	0.000279	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000118	0.000277	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—AKR1C3—polycystic ovary syndrome	0.000118	0.000277	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—PNPLA2—polycystic ovary syndrome	0.000116	0.000274	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—CYP17A1—polycystic ovary syndrome	0.000116	0.000272	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—LEP—polycystic ovary syndrome	0.000115	0.000271	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000114	0.000268	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000112	0.000264	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—SRD5A1—polycystic ovary syndrome	0.00011	0.000259	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—STAR—polycystic ovary syndrome	0.000105	0.000247	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000104	0.000245	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000103	0.000242	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—TH—polycystic ovary syndrome	0.0001	0.000236	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—PNPLA2—polycystic ovary syndrome	9.94e-05	0.000234	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—POMC—polycystic ovary syndrome	9.92e-05	0.000233	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—INS—polycystic ovary syndrome	9.86e-05	0.000232	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—SLC2A4—polycystic ovary syndrome	9.76e-05	0.000229	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—IGF1—polycystic ovary syndrome	9.54e-05	0.000224	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—AKT2—polycystic ovary syndrome	9.53e-05	0.000224	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—SRD5A1—polycystic ovary syndrome	9.43e-05	0.000222	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—HMMR—polycystic ovary syndrome	9.38e-05	0.000221	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—CYP19A1—polycystic ovary syndrome	9.17e-05	0.000216	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—SERPINE1—polycystic ovary syndrome	9.06e-05	0.000213	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—STAR—polycystic ovary syndrome	8.99e-05	0.000211	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—HSD3B1—polycystic ovary syndrome	8.95e-05	0.00021	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	8.89e-05	0.000209	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	8.85e-05	0.000208	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	8.39e-05	0.000197	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—GNAS—polycystic ovary syndrome	8.19e-05	0.000192	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—LHB—polycystic ovary syndrome	8.16e-05	0.000192	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—HMMR—polycystic ovary syndrome	8.02e-05	0.000188	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—HSD3B2—polycystic ovary syndrome	7.98e-05	0.000187	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—NCOR1—polycystic ovary syndrome	7.8e-05	0.000183	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—AKR1C1—polycystic ovary syndrome	7.72e-05	0.000182	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—HSD3B1—polycystic ovary syndrome	7.65e-05	0.00018	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	7.56e-05	0.000178	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—CYP1A1—polycystic ovary syndrome	7.39e-05	0.000174	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	7.17e-05	0.000168	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—SULT2A1—polycystic ovary syndrome	7.11e-05	0.000167	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—LHB—polycystic ovary syndrome	6.97e-05	0.000164	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—MTHFR—polycystic ovary syndrome	6.89e-05	0.000162	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—RRM2—polycystic ovary syndrome	6.89e-05	0.000162	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—HSD3B2—polycystic ovary syndrome	6.82e-05	0.00016	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—IL6—polycystic ovary syndrome	6.66e-05	0.000157	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—YAP1—polycystic ovary syndrome	6.64e-05	0.000156	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—AKR1C1—polycystic ovary syndrome	6.6e-05	0.000155	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—NAMPT—polycystic ovary syndrome	6.38e-05	0.00015	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	6.34e-05	0.000149	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—CYP11A1—polycystic ovary syndrome	6.3e-05	0.000148	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	6.25e-05	0.000147	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—VEGFA—polycystic ovary syndrome	6.23e-05	0.000146	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—SULT2A1—polycystic ovary syndrome	6.08e-05	0.000143	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—AKR1C3—polycystic ovary syndrome	5.95e-05	0.00014	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—RRM2—polycystic ovary syndrome	5.88e-05	0.000138	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—CYP17A1—polycystic ovary syndrome	5.85e-05	0.000138	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—YAP1—polycystic ovary syndrome	5.67e-05	0.000133	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—PPARG—polycystic ovary syndrome	5.59e-05	0.000131	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—POMC—polycystic ovary syndrome	5.51e-05	0.00013	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—INS—polycystic ovary syndrome	5.48e-05	0.000129	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—NAMPT—polycystic ovary syndrome	5.45e-05	0.000128	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	5.42e-05	0.000127	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—CYP11A1—polycystic ovary syndrome	5.38e-05	0.000126	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	5.34e-05	0.000126	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—AKR1C3—polycystic ovary syndrome	5.08e-05	0.000119	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—TH—polycystic ovary syndrome	5.07e-05	0.000119	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—CYP17A1—polycystic ovary syndrome	5e-05	0.000118	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—SLC2A4—polycystic ovary syndrome	4.93e-05	0.000116	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—CYP19A1—polycystic ovary syndrome	4.63e-05	0.000109	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—TH—polycystic ovary syndrome	4.33e-05	0.000102	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—IL6—polycystic ovary syndrome	4.31e-05	0.000101	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—SLC2A4—polycystic ovary syndrome	4.21e-05	9.9e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—GNAS—polycystic ovary syndrome	4.14e-05	9.72e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—CYP19A1—polycystic ovary syndrome	3.96e-05	9.31e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—NCOR1—polycystic ovary syndrome	3.94e-05	9.26e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—CYP1A1—polycystic ovary syndrome	3.73e-05	8.78e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—GNAS—polycystic ovary syndrome	3.53e-05	8.31e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—MTHFR—polycystic ovary syndrome	3.48e-05	8.18e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—NCOR1—polycystic ovary syndrome	3.37e-05	7.91e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—CYP1A1—polycystic ovary syndrome	3.19e-05	7.5e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—MTHFR—polycystic ovary syndrome	2.98e-05	6.99e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—PPARG—polycystic ovary syndrome	2.82e-05	6.64e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—POMC—polycystic ovary syndrome	2.78e-05	6.55e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—INS—polycystic ovary syndrome	2.77e-05	6.51e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—PPARG—polycystic ovary syndrome	2.41e-05	5.67e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—POMC—polycystic ovary syndrome	2.38e-05	5.59e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—INS—polycystic ovary syndrome	2.37e-05	5.56e-05	CbGpPWpGaD
